Elizabeth is a UK Chartered and European Patent Attorney. She joined Dehns in 1993, was made a Partner in 2001 and is a senior member of Dehns’ Life Sciences and Biotechnology group. She holds a number of Chemistry and Biochemistry related degrees from the University of Cape Town and was awarded a PhD by the Open University. Elizabeth is a former Managing Partner and in 2022 was elected Senior Partner, responsible for the growth and continued development of the firm.
Elizabeth’s clients include sole inventors and small companies, as well as University Technology Transfer Offices and multinationals. She provides a range of services including patentability assessments, drafting, filing and prosecuting patent applications, defending and opposing granted patents and providing advice on aspects such as due diligence, infringement, validity and freedom to practice.
Elizabeth handles patent work in the general fields of biochemistry and biotechnology, including genomics, proteomics, immunology, virology and microbiology, particularly in relation to molecular biology based inventions (such as recombinant products, transgenic plants and animals, genomic therapeutics and diagnostics), screening methods, purification protocols, diagnostic assays and therapeutic and prophylactic inventions.
PhD, Open University, “Cell signalling pathways of IL-1 and TNF”, 1993
MSc, University of Cape Town, Crystallographic determination of cholic acid:alcohol structures”, (awarded with distinction), 1989
BSc (Hons), University of Cape Town, Biochemistry, 1986
BSc, University of Cape Town, Chemistry and Biochemistry (distinction in Chemistry), 1985
Elizabeth was named as “Patent Attorney of the Year – UK” at the Women in Business Legal Awards 2017. She was also mentioned in The Legal 500 2022 edition.